You are here

Article Text

Article menu
Download PDFPDF
Case report
Propofol for palliative sedation
  1. Merlina Sulistio1,2,
  2. Robert Wojnar1 and
  3. Natasha G Michael1,2,3
  1. 1 Department of Palliative and Supportive Care, Cabrini Health, Melbourne, Victoria, Australia
  2. 2 Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
  3. 3 School of Medicine, University of Notre Dame, Sydney, New South Wales, Australia
  1. Correspondence to Dr Merlina Sulistio, Supportive and Palliative Care Unit, Cabrini Health, Prahran, VIC 3181, Australia; msulistio{at}cabrini.com.au

Abstract

Palliative sedation is the intentional use of sedatives to manage refractory symptom(s), such as pain and/or terminal restlessness. This case report describes the successful use of propofol, an ultra-fast-acting anaesthetic agent commonly used for anaesthesia induction and maintenance to manage refractory agitated delirium in an acute inpatient palliative medicine setting.

  • propofol
  • sedative
  • sedation
  • palliative care
  • end of life care

https://doi.org/10.1136/bmjspcare-2019-001899

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Background research by MS and RW. Article written by MS and RW with editorial input from NGM. Article submitted by MS. The guarantor for content is MS.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Next-of-kin consent obtained.

    • Provenance and peer review Not commissioned; internally peer reviewed.